Another article also reported that lncRNA NCK1-AS1 could increase drug resistance of GBM cells to TMZ by modulating miR-137/TRIM24 (12), prompting that miR-137 may associate with GBM chemosensitivity. This evidence concerns the gene NCK1 and glioblastoma.